Patients with chest pain account for a substantial number of emergency department (ED) visits. 1 While early identification of acute coronary syndrome (ACS) in these patients is essential, current guidelines also support rapid identification and safe discharge of patients at low risk of ACS. [2] [3] [4] In these low-risk patients, noninvasive cardiac testing modes-specifically exercise treadmill testing (ETT), stress single-photon emission CT (SPECT) myocardial perfusion imaging (MPI), stress positron emission tomography (PET) MPI, cardiac CT angiography (CCTA), or stress echocardiography-are currently recommended prior to or within 72 hours after ED-discharge. 2 In the present issue of JNC, Liti et al. describe their findings after instituting a novel protocol to expedite evaluation of low-risk patients presenting to the ED with acute chest pain. Their protocol for these patients emphasizes early discharge home after normal serial troponin and ECG assessments, followed by early outpatient stress testing using evidence-based radiationreduction strategies. Their study demonstrates that such a strategy is safe, reduces length of stay within the ED, and markedly reduces radiation exposure compared to a historical control cohort. These encouraging findings in a 'real-world' clinical population are highly encouraging and suggest that a structured protocol including simultaneous implementation of previously isolated evidencebased practices has the potential to yield new operational efficiencies while maintaining safe and effective patient care. However, we believe there is still room for additional improvement with the integration of additional components into the algorithm: (1) an alternative 'no-test' option for selected patients, and (2) addition of CCTA as an option after ED-discharge.
EMERGING DATA SUGGEST IT MAY BE SAFE TO AVOID NONINVASIVE CARDIAC TESTING AFTER NORMAL SERIAL HIGH-SENSITIVITY CARDIAC TROPONIN TESTING
Liti et al. included a requirement for 'at least 2 sets of negative cardiac troponins' in their definition of lowrisk patients. While they did not specifically state whether their institution uses high-sensitivity cardiac troponin (hs-cTn) assays or older conventional assays, the former are now being increasingly adopted by EDs in the United States and have enabled more rapid ruleout of myocardial infarction. 5 The ROMICAT investigators recently presented data suggesting that negative serial hs-cTn evaluation in the ED in low-risk patients (which they defined as those with \ 2 cardiovascular risk factors) may allow for safe avoidance of noninvasive cardiac testing altogether. Based on these criteria, they found that 29% of ROMICAT II cohort did not need cardiac testing. 6 Other recent clinical cohort studies also suggest that routine noninvasive cardiac testing in low-risk patients has exceptionally low diagnostic yield and positive predictive value and therefore might be avoided altogether. 7, 8 Data from Liti et al. support this approach, as their manuscript states 'no deaths, myocardial infarctions, or revascularization procedures and no differences in cardiac hospitalizations' occurred in the almost 30% of low-risk patients who did not follow up as planned within 72 hours for noninvasive cardiac testing. Therefore, adding a 'no-test' option appears to be reasonable for selected patients and, if instituted, would result in further reductions in radiation exposure to patients and in healthcare costs. Importantly, even when this 'no-test' option is considered, clinicians should still use the pooled cohort equation to assess patients' global 10-year atherosclerotic cardiovascular disease risk and make any appropriate changes in medical therapy for primary prevention of adverse cardiovascular events (i.e., statin initiation).
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WHILE ALL FUNCTIONAL AND ANATOMIC TESTING MODALITIES ARE REASONABLE TO CONSIDER FOR POST-DISCHARGE NONINVASIVE CARDIAC TESTING, CARDIAC CT ANGIOGRAPHY MAY BE THE PREFERRED OPTION
In their protocol, Liti et al. performed ETT with provisional MPI and pharmacologic stress MPI in the early post-discharge period. The authors did not specify whether MPI was performed exclusively with SPECT, PET, or a combination of both. They also either did not perform other tests such as CCTA or stress echocardiography, or they did not include patients in whom these tests were performed in their selected study cohort. Current CCTA technology has made it possible to perform scans with effective radiation doses roughly equivalent to stress-only SPECT MPI. 11 Although CCTA may lead to an increase in the use of invasive angiography and revascularizations in the ER, 12 recent data from stable chest pain trials suggest that CCTA may provide better prognostic information than functional testing in low-risk patients due its ability to identify nonobstructive epicardial coronary artery disease (CAD). This may drive Figure 1 . Proposed evidence-based algorithm to safely and efficiently evaluate low-risk patients presenting to the ED with chest pain. *Low risk is defined as no known coronary artery disease, nonischemic initial electrocardiogram, HEART score 3 of 0-3, and serial (high-sensitivity) cardiac troponins \ 99th percentile. ASCVD, atherosclerotic cardiovascular disease; ED, emergency department; hs-cTN, high sensitivity cardiac troponin. increased use of preventative therapies like statins, leading to a reduction in incident myocardial infarction. 13, 14 For these reasons, CCTA may be the preferred modality for low-risk patients in whom clinical suspicion of obstructive CAD as the etiology of symptoms remains sufficiently high to warrant further evaluvation. 15 For patients with an absolute or relative contraindications to CCTA (e.g., renal failure, iodine contrast allergy), the functional testing protocol described by Liti et al. seems to be a reasonable alternative, although stress echocardiography should also be considered as an option in experienced centers. Furthermore, functional testing may be preferable over CCTA when a patient's clinical response to physical exercise is of interest (e.g., exerciseinduced arrhythmia suspected as the primary etiology of chest pain). Finally, whenever SPECT or PET MPI is performed using SPECT-CT or PET-CT machines, the addition of coronary artery calcium (CAC) scoring may provide significant additional prognostic value and should be considered routine. 16 Figure 1 succinctly summarizes the protocol tested by Liti et al. along with the additional evidence-based algorithmic modifications proposed above. We openly acknowledge that there is clinical variation in the definition of 'low risk' ED evaluation and that our proposed definition is therefore subjective. Also, as shown, we believe the 'no-test' option should be the default in lowrisk patients discharged from the ED although postdischarge testing may be appropriate for selected individuals. Notably, we did not include the same 72-hour requirement for testing to be completed after discharge, as we do not believe there is sufficient evidence to justify this practice, nor is it feasible in many centers. Those caveats aside, we believe the combination of evidence from the current study with additional recent data on the evaluation of acute chest pain, as illustrated by this algorithm, will likely help to promote safe and efficient evaluation of lowrisk patients presenting to the ED.
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